Screener
Stryker SYK Orthopaedics — Foreign exchange and other
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stryker in its filing.
Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.
The source filing: Stryker’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 11:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000310764-26-000031
FAQ
- What is Stryker's orthopaedics — foreign exchange and other?
- Stryker (SYK) reported orthopaedics — foreign exchange and other of -$10M in Q1 2026.
- How has Stryker's orthopaedics — foreign exchange and other changed year-over-year?
- Stryker's orthopaedics — foreign exchange and other decreased by 144.9% year-over-year, from $22.25M to -$10M.
- What is the long-term trend for Stryker's orthopaedics — foreign exchange and other?
- Over 4 years (2021 to 2025), Stryker's orthopaedics — foreign exchange and other has grown at a -8.9% compound annual growth rate (CAGR), from -$129M to $89M.
- What does orthopaedics — foreign exchange and other mean?
- Captures the impact of currency fluctuations and miscellaneous non-operating factors on the Orthopaedics segment's financial performance. This metric isolates the volatility caused by global market conditions rather than operational execution within the orthopedic product lines. It is essential for distinguishing between organic growth and gains or losses driven by macroeconomic currency shifts.
Ask your AI about Stryker's orthopaedics — foreign exchange and other.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude